| Application no. and date | 21174219.2 (espacenet) (Federated) (European Patent Register), 20120323 | | Patent/reg. no. and date | DK/EP 4011364, 20231213 | | Publication date | 20220615 | | Priority no. and date | US 201161466684 P, 20110323, US 201161561763 P, 20111118, US 201261591129 P, 20120126 | | EP pub. no. and date |
EP 4011364 20220615 | | Effective date | | | Applicant/owner | Ironshore Pharmaceuticals & Development, Inc., 10 Market Street, Suite 715
Camana Bay 1-9006, KY | | Applicant ref. no. | P249685.DK.02//OGUNJEMILUSIM | | Inventor | LICKRISH, David,
1-9006 Camana Bay, KY,
ZHANG, Feng,
1-9006 Camana Bay, KY | | Representative | Murgitroyd & Company, Mannerheimvägen 12 B
5:e våningen
FI-00100 Helsingfors, FI | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/4458 (2006.01) , A61K 9/50 (2006.01) | | Title | Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
